Findings from the post-hoc analysis of LIBERTY-CD study indicates efficacy of ZYMFENTRA® (subcutaneous infliximab) regardless ...

Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive ...

Alzheimer’s disease is the most commonly diagnosed form of dementia, but it’s far from the only one. In fact, most people who ...

For more than two decades, researchers at the University of Basel, Switzerland, have been investigating a severe form of ...

Parkinson's disease affects more than 1.1 million people in the United States, progressively damaging the brain cells that ...

Engineered T cells that have been used to treat ulcerative colitis, rheumatoid arthritis and lupus show promising results.

A 12-year-old boy was diagnosed with acute flaccid myelitis (AFM), a rare neurological condition affecting the spinal cord.

Bristol Myers Squibb today announced the presentation of more than 95 data disclosures, including 27 oral presentations, across company-sponsored studies and external collaborations at the 67th ...

Individuals with coronary artery disease (CAD) - a constricting or blocking of blood vessels feeding the heart - face ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) has been approved in the US for the treatment of adult ...

Winter's colder temperatures and shorter days can worsen autoimmune symptoms due to decreased vitamin D, disrupted sleep, ...

But in people with dementia —which is an umbrella term for mental decline and can be related to a number of diseases such as ...